key: cord-0729036-4xtdjly8
authors: Moss, Daniel L.; Rappaport, Jay
title: The good, the bad and the ugly: G‐CSF, ageing and neutrophils—Implications for severe COVID‐19
date: 2021-04-18
journal: J Leukoc Biol
DOI: 10.1002/jlb.3ce0121-002r
sha: 2572edbae79675abe788b94517fef3b7e79ae94c
doc_id: 729036
cord_uid: 4xtdjly8

Neutrophil dynamics in aging provide another key piece of the puzzle regarding the impact of aging and comorbid conditions on the severity of Covid‐19. [Image: see text]

In the current issue of the Journal of Leukocyte Biology, He et al.

report the observation that aged rhesus macaques contain fewer blood neutrophils despite higher levels of circulating Granulocyte colony stimulating factor (G-CSF), a major growth factor that drives neutrophil production in the bone marrow (BM). 2 Elevated G-CSF in older macaques was also positively correlated with higher levels of other proinflammatory cytokines such as IL-1β and MIF-1α. Furthermore, the authors observed that older macaques release neutrophils from the BM earlier than their younger counterparts and that these neutrophils are less functional. Some of these cells also possess a phenotype similar to polymorphonuclear myeloid-derived suppressor cells. This paradoxical decline in blood neutrophils despite elevated G-CSF and the observation that blood neutrophils within aged rhesus macaques are less functional may shed some light on how ageing increases the risk of runaway innate immune activation resulting in poorer infection outcomes.

Senescence of hematopoietic stem cells resulting from biological aging may cause a decline in blood neutrophil numbers resulting in a homeostatic response increasing G-CSF production to compensate. Increased GM-CSF in the serum has been reported in type 2 diabetic subjects and is correlated with HbA1c levels. 4 In mice, obesity has been associated with elevated levels of inflammatory cytokines in a GM-CSF-dependent manner 5 and alter myeloid cell presence in the lung along with G-CSF. 6 In conditions, where GM-CSF and G-CSF are elevated, susceptibility to SARS-CoV-2 severe disease would be predicted.

For example, exogenous G-CSF provided to cancer patients to prevent neutropenia and infection has been associated with increased need for supplemental oxygen and death. 12 This model emphasizes the role of GM-CSF and G-CSF as therapeutic targets for COVID-19 treatment.

Indeed, blocking GM-CSF with a monoclonal antibody has been shown to improve severe COVID-19 outcomes in human subjects. 13 Other studies have shown that targeting G-CSF and its receptor (G-CSFR) with monoclonal antibodies can also mitigate neutrophil-dependent inflammatory responses. 14 A combinational approach in which both G-CSF and GM-CSF are targeted in severe COVID-19 may be even more effective. In our opinion, the findings reported by He and colleagues provide evidence for a link between aging and impaired neutrophil function that may help explained impaired innate immune cell function and resulting disease severity associated with severe COVID-19 infection.

In summary, He et al. report increased G-CSF levels in aged rhesus macaques that is associated with earlier neutrophil release from the BM. High G-CSF in these animals is associated with higher levels of 

Young patient 

Inflammaging: a new immune-metabolic viewpoint for age-related diseases

Phagocytosis of Apoptotic Neutrophils Regulates Granulopoiesis via IL-23 and IL-17

Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: a systematic review and meta-analysis

Increased levels of serum granulocyte-macrophage colony-stimulating factor is associated with activated peripheral dendritic cells in type 2 diabetes subjects (CURES-99)

The role of GM-CSF in adipose tissue inflammation

Obesity alters the lung myeloid cell landscape to enhance breast cancer metastasis through IL5 and GM-CSF

The emerging role of neutrophil extracellular traps in severe acute respiratory syndrome coronavirus 2 (COVID-19)

Targeting potential drivers of COVID-19: neutrophil extracellular traps

Cellular events of acute, resolving or progressive COVID-19 in SARS-CoV-2 infected non-human primates

Circulating markers of neutrophil extracellular traps are of prognostic value in patients with COVID-19

Emergency granulopoiesis

The effect of neutropenia and filgrastim (G-CSF) in cancer patients with COVID-19 infection

GM-CSF neutralization with lenzilumab in severe COVID-19 pneumonia: a case-cohort study

A neutralizing anti-G-CSFR antibody blocks G-CSF-induced neutrophilia without inducing neutropenia in nonhuman primates